Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials

The main objective of this post hoc analysis is to compare the magnitude of the immune response to HPV31/33/45/52 and 58 after a dose of 9vHPV vaccine given to naïve (previously unvaccinated) subjects and subjects previously vaccinated with a dose of 2vHPV or 4vHPV vaccine. Results from two clinical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Sauvageau, Chantal, Panicker, Gitika, Unger, Elizabeth R., De Serres, Gaston, Schiller, John, Ouakki, Manale, Gilca, Vladimir
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2019
Materias:
Short Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227663/
https://ncbi.nlm.nih.gov/pubmed/31545130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1669413
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares